News & Updates
Filter by Specialty:
Accelerated daratumumab infusion safe, well tolerated in multiple myeloma
Accelerated administration of daratumumab, an anti-CD3 monoclonal antibody approved for multiple myeloma, is safe and well tolerated when given following at least two standard infusions, suggest the results of a recent study.
Accelerated daratumumab infusion safe, well tolerated in multiple myeloma
29 May 2022
Chemoradiotherapy improves disease control in muscle-invasive bladder cancer
Chemotherapy with 5-fluorouracil (5FU) and mitomycin C (MMC), when combined with radiotherapy, leads to better locoregional control over a 10-year window in patients with muscle-invasive bladder cancer (MIBC), a recent study has found.
Chemoradiotherapy improves disease control in muscle-invasive bladder cancer
28 May 2022
Compromised nutritional, immunological status ups infection risk after gastric cancer surgery
Infection is a common complication in gastric cancer stage II/III patients after gastrectomy, a recent study has found. A low prognostic nutritional index score seems to be an important risk factor for such an outcome.
Compromised nutritional, immunological status ups infection risk after gastric cancer surgery
27 May 2022
Preop radiotherapy, immediate reconstruction feasible in breast cancer patients
Preoperative radiotherapy (preop RT), followed by skin-sparing mastectomy and immediate deep inferior epigastric perforator (DIEP) flap reconstruction, is technically feasible and safe in breast cancer patients who require mastectomy, the PRADA* trial suggests.